Antares Therapeutics · Domain Security

Antares Therapeutics Domain Security

Domain security

Domain security posture for Antares Therapeutics, probed live across 1 host(s) and 1 registrable domain(s). 1 host(s) serve HTTPS (up to TLSv1.3); 1 advertise HSTS. Email/DNS controls: DNSSEC absent, SPF present, DMARC present (p=reject).

CompanyBiotechnologyPharmaceuticalsPrecision MedicineOncologyDrug DiscoveryLife SciencesMachine Learning

Transport & Host Security

antaresrx.com
HTTPS: yes · TLS: TLSv1.3 · HSTS: yes · cert expires: Sep 4 13:10:50 2026 GMT

Domain (DNS/Email) Security

antaresrx.com
DNSSEC: no · SPF: yes · DMARC: yes (p=reject) · CAA: none

Source

Domain Security

antares-therapeutics-domain-security.yml Raw ↑ 
generated: '2026-07-19'
method: probed
source: live DNS/TLS/HTTP probes of apis.yml + OpenAPI hosts
hosts:
- host: antaresrx.com
  https: true
  tls_version: TLSv1.3
  cert_expires: Sep  4 13:10:50 2026 GMT
  hsts: true
  hsts_max_age: 31536000
domains:
- domain: antaresrx.com
  dnssec: false
  caa: []
  caa_note: >-
    No CAA records published. The initial probe recorded a resolver timeout; re-probed
    against 8.8.8.8 and 1.1.1.1 on 2026-07-19, both returned an empty answer.
  spf: true
  dmarc: true
  dmarc_policy: reject